References
- O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 1988;2:397.
- Cuspidi C, Meani S, Valerio C, et al. Nocturnal non-dipping pattern in untreated hypertensives at different cardiovascular risk according to the 2003 ESH/ESC guidelines. Blood Press. 2006;15:37–44.
- Ukkola O, Vasunta R, Kesäniemi YA. Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects. Hypertens Res. 2009;32:1022–1027.
- Minutolo R, Agarwal R, Borrelli S, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090–1098.
- Hansen TW, Jeppesen J, Rasmussen S, et al. Ambulatory blood pressure and mortality: a population-based study. Hypertension. 2005;45:499–504.
- Kikuya M, Ohkubo T, Asayama K, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension. 2005;45:240–245.
- Draman MS, Dolan E, van der Poel L, et al. The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study. J Hypertens.2015;33:1373–1377.
- Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens.2002;20:2183–2189.
- Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378:1509–1520.
- Taylor KS, Heneghan CJ, Stevens RJ, et al. Heterogeneity of prognostic studies of 24-hour blood pressure variability: systematic review and meta-analysis. PLoS One. 2015;10:e0126375.
- Satoh M, Asayama K, Kikuya M, et al. Nocturnal blood pressure decline based on different time intervals and long-term cardiovascular risk: the Ohasama Study. Clin Exp Hypertens. 2018;40:1–7.
- Hermida RC, Ayala DE, Mojón A, et al. Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention. Diabetologia 2016;59:244–254.
- Hermida RC, Ayala DE, Mojón A, et al. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Diabetologia 2016;59:255–265.
- Parati G, Stergiou G, O’Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359–1366.
- Rantala AO, Kauma H, Lilja M, et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245:163–174.
- Leinonen T, Kesäniemi YA, Hedberg P, et al. Serum ghrelin and prediction of metabolic parameters in over 20-year follow-up. Peptides 2016;76:51–56.
- Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553.
- Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006. 23:469–480.
- Reinders A, Reggiori F, Shennan AH. Validation of the DINAMAP ProCare blood pressure device according to the international protocol in an adult population. Blood Press Monit. 2006;11:293–296.
- Goodwin J, Bilous M, Winship S, et al. Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit. 2007;12:113–117.
- IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. 2017.
- Mancia G, Bombelli M, Facchetti R, et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens. 2009;27:1672–1678.
- Sun L, Yan B, Gao Y, et al. Relationship between blood pressure reverse dipping and type 2 diabetes in hypertensive patients. Sci Rep. 2016;6:25053.
- Kastarinen H, Vasunta RL, Ukkola O, et al. Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring–a cross-sectional population-based study. J Hum Hypertens. 2010;24:247–253.
- Weir MR, Reisin E, Falkner B, et al. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. Am J Hypertens. 1998;11:914–920.
- Hermida RC, Ayala DE, Calvo C, et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension. 2005;46:1053–1059.
- Scuteri A, Tesauro M, Guglini L, et al. Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol. 2013;169:371–377.
- Di Daniele N, Fegatelli DA, Rovella V, et al. Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease. Atherosclerosis 2017;267:139–145.
- Scuteri A, Stuehlinger MC, Cooke JP, et al. Nitric oxide inhibition as a mechanism for blood pressure increase during salt loading in normotensive postmenopausal women. J Hypertens. 2003;21:1339–1346.
- Scuteri A, Morrell CH, Orru’ M, et al. Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. Int J Cardiol. 2016;217:92–98.
- Scuteri A, Tesauro M, Rizza S, et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2008;18:349–356.
- Scuteri A, Orru M, Morrell C, et al. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 2011;215:459–464.
- Rahman A, Hasan AU, Nishiyama A, et al. Altered circadian timing system-mediated non-dipping pattern of blood pressure and associated cardiovascular disorders in metabolic and kidney diseases. IJMS. 2018;19:400.
- Sookoian S, Gianotti TF, Burgueno A, et al. Gene-gene interaction between serotonin transporter (SLC6A4) and CLOCK modulates the risk of metabolic syndrome in rotating shiftworkers. Chronobiol Int. 2010;27:1202–1218.
- Young ME, Wilson CR, Razeghi P, et al. Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol. 2002;34:223–231.
- Hinderliter AL, Routledge FS, Blumenthal JA, et al. Reproducibility of blood pressure dipping: relation to day-to-day variability in sleep quality. J Am Soc Hypertens. 2013;7:432–439.
- Stenehjem AE, Os I. Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension. Blood Press. 2004;13:214–224.
- McGowan NJ, Gough K, Padfield PL. Nocturnal dipping is reproducible in the long term. Blood Press Monit. 2009;14:185–189.
- Mochizuki Y, Okutani M, Donfeng Y, et al. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens. 1998;11:403–409.
- Keren S, Leibowitz A, Grossman E, et al. Limited reproducibility of 24-h ambulatory blood pressure monitoring. Clin Exp Hypertens. 2015;37:599–603.
- Cuspidi C, Meani S, Lonati L, et al. Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J Hypertens. 2006;24:647–653.
- Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens. 1998;16:733–738.
- Mancia G, Verdecchia P. Clinical value of ambulatory blood pressure: evidence and limits. Circ Res. 2015;116:1034–1045.